miR-139-5p was selected from the downregulated miRNAs in KRAS-mutant cells for further investigation because it has been reported to be a tumor suppressor in several cancer types 16, 17, 25, yet its relation to KRAS mutation remains unclear. This evidence concerns the gene KRAS and neoplasm.